Skip to main content

Advancing Precision Oncology Through Artificial Intelligence

By Waqas Haque, MD, MPH

In this latest edition of The Way Ahead: The Convergence of Technology and Cancer Care, Dr. Waqas Haque shares his perspectives on machine learning models for classifying cancer immunophenotypes in lung cancer; Insilico Medicine's artificial intelligence–driven process behind the development of INS018_055, a promising drug for idiopathic pulmonary fibrosis; the approval of lisocabtagene maraleucel for chronic lymphocytic leukemia/small lymphocytic lymphoma; and more! 

Continue reading

Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes With Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan

In this edition of Oncology Data Advisor celebrating Kidney Cancer Awareness Month Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan discuss the rising incidence of kidney cancer, warning signs and symptoms to look out for, environmental risk factors such as tobacco use, emerging treatment strategies using immunotherapy and adjuvant therapy, considerations for genetic testing, and the importance of clinical trial participation for bringing these new advances to the forefront of care. 

Continue reading

Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes With Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan

In this edition of Oncology Data Advisor celebrating Kidney Cancer Awareness Month Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan discuss the rising incidence of kidney cancer, warning signs and symptoms to look out for, environmental risk factors such as tobacco use, emerging treatment strategies using immunotherapy and adjuvant therapy, considerations for genetic testing, and the importance of clinical trial participation for bringing these new advances to the forefront of care.

Continue reading

Emerging Technologies in Therapeutics and Diagnostics

By Waqas Haque, MD, MPH

In this latest edition of The Way Ahead: The Convergence of Technology and Cancer Care, Dr. Waqas Haque shares his perspectives on the approval of lifileucel, the first individualized tumor-infiltrating lymphocyte therapy, for advanced melanoma; updates on the EV-302 trial of enfortumab vedotin, an antibody-drug conjugate technology; a new blood test for colorectal cancer screening from Guardant Health; the Model Facts label to guide decisions using machine learning; and more!  

Continue reading

Expanding Access to Clinical Trials Through Decentralized Methods and Technology With Waqas Haque, MD, MPH, and Shaalan Beg, MD

In this installment of Oncology Data Advisor's Exploring AI in Oncology series, Dr. Waqas Haque speaks with Dr. Shaalan Beg, an Adjunct Associate Professor at the University of Texas (UT) Southwestern, who is spearheading efforts to decentralize clinical trials in oncology and expand access for eligible patients. Dr. Beg describes the tools that are currently in development for decentralizing trials, including the use of artificial intelligence (AI), natural language processing, and telehealth. Additionally, he shares his perspectives on transitioning to a career in industry.  

Continue reading

New Podcast Series: "Exploring Artificial Intelligence in Oncology"

New podcast series! Oncology Data Advisor is excited to launch our new series, "Exploring Artificial Intelligence in Oncology." Hosted by Waqas Haque, MD, MPH, Member of the Oncology Data Advisor Fellows Forum, this series will delve into the burgeoning roles and uses of AI in cancer care, from pathology to toxicity risk prediction to treatment recommendations and beyond.  Subscribe to Oncology Data Advisor wherever you listen to your podcasts, and stay tuned for more episodes rel...

Continue reading

Expanding Access to Clinical Trials Through Decentralized Methods and Technology With Waqas Haque, MD, MPH, and Shaalan Beg, MD

In this installment of Oncology Data Advisor's Exploring AI in Oncology series, Dr. Waqas Haque speaks with Dr. Shaalan Beg, an Adjunct Associate Professor at the University of Texas (UT) Southwestern, who is spearheading efforts to decentralize clinical trials in oncology and expand access for eligible patients. Dr. Beg describes the tools that are currently in development for decentralizing trials, including the use of artificial intelligence (AI), natural language processing, and telehealth. Additionally, he shares his perspectives on transitioning to a career in industry.  

Continue reading

National Cancer Prevention Month: Rising Trends and How to Combat Them With Samuel Kareff, Matthew Hadfield, Waqas Haque, and Joseph Kalis

In honor of National Cancer Prevention Month 2024, members of the Oncology Data Advisor Editorial Board and Fellows Forum sat down for a panel discussion about the rising incidence of cancer diagnoses, factors contributing to them, and how to counsel patients in light of these emerging trends.  

Continue reading

Gallbladder and Bile Duct Cancer Awareness Month: Improving Screening and Treatment Options With Waqas Haque, MD, MPH, and Matthew Hadfield, DO

In honor of Gallbladder and Bile Duct Cancer Awareness Month this February, Fellows Forum members Dr. Waqas Haque and Dr. Matthew Hadfield sat down for a discussion on the challenges in diagnosis of gallbladder and bile duct cancers and the importance of genetic sequencing for making targeted treatments available for patients.   Waqas Haque, MD, MPH: Hi everybody, thanks for joining our Oncology Data Advisor podcast today. My name is Waqas Haque. I'm a third-year Internal Medicine Resident ...

Continue reading

Updates on AI and Deep Learning for Cancer Detection and Outcomes Prediction

By Waqas Haque, MD, MPH

In this latest edition of The Way Ahead: The Convergence of Technology and Cancer Care, Dr. Waqas Haque shares his perspectives on a deep learning model for gallbladder cancer detection, a precision medicine platform for pancreatic ductal adenocarcinoma outcome prediction, and more!  

Continue reading

Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon

In this first episode of Oncology Data Advisor's new podcast series, "Exploring Artificial Intelligence in Cancer Care," Dr. Waqas Haque and Dr. Matthew Hadfield of the OncData Fellows Forum engage in a discussion with Dr. Ofer Sharon, CEO of OncoHost. Dr. Sharon provides an overview of the clinical need for increased knowledge of patients' probabilities of developing immune-related adverse events and explains the PROphet® platform, OncoHost's novel plasma-based, proteomic pattern analysis tool that uses a single blood sample to guide immunotherapy treatment decisions.  

Continue reading

Insights from the State of AI Precision Oncology Conference

By Waqas Haque, MD, MPH In a virtual seminar held on December 12 of last year, the State of AI Precision Oncology brought together a group of scientists and oncologists to delve into the transformative impact of artificial intelligence (AI) in oncology. Dr. Doug Flora, the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare and Chief Editor of the new journal, AI in Precision Oncology, curated discussions on early cancer detection, drug discovery, and data management. The...

Continue reading

The Way Ahead: The Convergence of Technology and Cancer Care: December 2023 Edition

By Waqas Haque, MD, MPH

In this new post of the Oncology Data Advisor Fellows Forum blog series, "Convergence of Technology and Cancer Care," Waqas Haque, MD, MPH, delves into the latest technological advancements seeking to improve the care and outcomes of patients with cancer. In this edition, Dr. Haque explores the potential of an artificial intelligence–based program for providing treatment recommendations, the FDA's groundbreaking approval of the first cell-based gene therapy for sickle cell disease, and integrating a diagonal approach for improving access to cancer treatments and technologies globally. 

Continue reading

World Cancer Research Day: How to Get Involved in Research With Waqas Haque, MD, MPH

In honor of World Cancer Research Day, Dr. Waqas Haque, a third-year Internal Medicine Resident at New York University (NYU) and Oncology Data Advisor Fellows Forum member, shares advice for residents and fellows who are interested in becoming involved in oncology research. Dr. Haque offers practical tips for finding a mentor, identifying and exploring a research topic, making time for projects amidst a busy schedule, balancing research with patient care, and much more.  

Continue reading

The Way Ahead: The Convergence of Technology and Cancer Care: November 2023 Edition

By Waqas Haque, MD, MPH This is the first post of our new blog series "The Way Ahead: Convergence of Technology and Cancer Care," in which we will delve into the latest technological advancements seeking to improve the care and outcomes of patients with cancer. In this edition, we explore the performance of a new artificial intelligence (AI) chatbot for providing National Comprehensive Cancer Network (NCCN) treatment recommendations, results of a multi-cancer early detection blood test stud...

Continue reading

World Cancer Research Day: How to Get Involved in Research With Waqas Haque, MD, MPH

In honor of World Cancer Research Day, Dr. Waqas Haque, a third-year Internal Medicine Resident at New York University (NYU) and Oncology Data Advisor Fellows Forum member, shares advice for residents and fellows who are interested in becoming involved in oncology research. Dr. Haque offers practical tips for finding a mentor, identifying and exploring a research topic, making time for projects amidst a busy schedule, balancing research with patient care, and much more.  

Continue reading

Navigating the Residency and Fellowship Experience by Creating Opportunities in Oncology With Waqas Haque, MD

In this Oncology Data Advisor® Fellows Forum interview, member Waqas Haque, MD, an Internal Medicine Resident at New York University, shares his medical training journey, the research he has conducted as Clinical Investigator Track Resident, his plans for applying to an oncology fellowship, advice for navigating the experience, tips for acquiring oncology exposure during residency, and much more!   Oncology Data Advisor: Welcome to the Oncology Data Advisor Fellows Forum. Today, I'm joined ...

Continue reading